61958-2005 : Descovy Oral Tablet
NDC: | 61958-2005 |
Labeler: | Gilead Sciences, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Descovy |
Dosage Form: | Oral Tablet |
Application #: | NDA208215 |
Rev. Date: |
NDC Package Codes:
- 61958-2005-1: 30 TABLET IN 1 BOTTLE, PLASTIC (61958‑2005‑1)
Active Ingredients:
- Emtricitabine
- Tenofovir Alafenamide Fumarate
Dosage Strength:
- 120 mg
- 15 mg
Pharmaceutical Classes:
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Nucleoside Reverse Transcriptase Inhibitors [MoA]
- Nucleosides [CS]
Related Products:
Based on records with the same trade name.- 61958-2002 Descovy Oral Tablet by Gilead Sciences, Inc.
- 70518-0230 Descovy Oral Tablet by Remedyrepack Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 61958-2002Next: 61958-2101 >
Related Discussions:
Tenofovir with primolut N
Actually I am taking tenofovir from the past 2 years. Now I need to take primolut N. Can I take it with tenofovir? One o...
Actually I am taking tenofovir from the past 2 years. Now I need to take primolut N. Can I take it with tenofovir? One o...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.